VIVUS to Present at Piper Jaffray 31st Annual Healthcare Conference on December 3, 2019
November 25 2019 - 7:30AM
VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical
company, today announced that John Amos, Chief Executive Officer at
VIVUS, will present at the Piper Jaffray 31st Annual Healthcare
Conference at 1:10 P.M. ET on Tuesday, December 3, 2019 in New
York.
An audio webcast of the presentation will be
available in the events and presentations section of the Company’s
investor relations website, or by clicking here.
About VIVUS
VIVUS is a biopharmaceutical company
committed to the development and commercialization of innovative
therapies that focus on advancing treatments for patients with
serious unmet medical needs. For more information about the
Company, please visit www.vivus.com.
Forward-Looking Statements
Certain statements in this press release are
forward-looking within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements may be identified
by the use of forward-looking words such as “anticipate,”
“believe,” “forecast,” “estimate,” “expect,” “intend,” “likely,”
“may,” “plan,” “potential,” “predict,” “opportunity” and “should,”
among others. There are a number of factors that could cause actual
events to differ materially from those indicated by such
forward-looking statements. VIVUS does not undertake an
obligation to update or revise any forward-looking statements.
Investors should read the risk factors set forth in VIVUS’ Form
10-K for the year ended December 31, 2018 as filed
on February 26, 2019, and periodic reports filed with
the Securities and Exchange Commission. VIVUS does
not undertake an obligation to update or revise any forward-looking
statements.
Contact:
VIVUS,
Inc. |
Lazar
FINN Partners |
Mark Oki |
David Carey |
Chief Financial Officer |
Senior Partner |
oki@vivus.com |
david.carey@finnpartners.com |
650-934-5200 |
212-687-1768 |
VIVUS (NASDAQ:VVUS)
Historical Stock Chart
From Mar 2024 to Apr 2024
VIVUS (NASDAQ:VVUS)
Historical Stock Chart
From Apr 2023 to Apr 2024